PR Newswire
NEW YORK, Nov. 16, 2026
QuidelOrtho shares fell roughly 14% after third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. Levi & Korsinsky is investigating on behalf of investors who lost money.
NEW YORK, Nov. 16, 2026 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) shares fell approximately 14% after the Company's third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. If you held QDEL when those results were released, the decline may have hit your account directly. Investors who suffered losses are encouraged to submit your loss details now or to contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
The declines centered on specific parts of the business. According to the Company's earnings materials, the 45% drop in China revenue was tied to distributor destocking and pricing changes. Point-of-Care revenue fell 27% in the same quarter, and total sales fell roughly 12% from the prior-year period.
QuidelOrtho's May 6, 2026 Form 10-Q referenced China's volume-based procurement (VBP) program, a government-led purchasing system for medical products. Levi & Korsinsky is investigating potential securities law violations on behalf of QDEL investors. The investigation focuses on the Company's exposure to China pricing and to demand for respiratory testing.
Lost money on QDEL? Start your no-cost loss review today or call (212) 363-7500.
ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.
Frequently Asked Questions About the QDEL Investigation
Q: Who is conducting the QDEL investigation? A: Levi & Korsinsky, LLP is investigating potential securities law claims on behalf of investors who purchased QDEL securities. The firm is nationally recognized and has been ranked in the ISS Top 50 for seven consecutive years.
Q: Who is eligible to participate in the QDEL investigation? A: Investors who purchased QDEL stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: How much did QDEL stock drop? A: Shares fell approximately 14% after the Company disclosed third-quarter 2026 results. Those results showed China revenue down 45%, Point-of-Care revenue down 27%, and respiratory revenue down 39%. Investors who purchased shares and suffered losses may be eligible to seek compensation.
Q: What do QDEL investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my QDEL shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought QDEL and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-qdel-securities-investigation-notice---levi--korsinsky-302939289.html
SOURCE Levi & Korsinsky, LLP
